SecBot SecBot

PHIO

Phio Pharmaceuticals Corp.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001533040 Biotech & Drug Discovery
$0.7520 −0.02 (−2.46%)
Nov 16 4:00 PM ET · prev $0.7710
Market cap
$9.7M
Nano cap
Consensus
Buy
86% Buy or better · 7 analysts
Median target
🔒 Subscribers only
1 year
−43.0%
from $1.32 · Nov 17
30 days
−13.5%
from $0.8690
52-week range
$0.7520–1.65
at the low
Avg volume 20D
62.9K
shares / day
Short interest
86.3K
≈0.7% of shares · −36.7%
Days to cover
1.5
at average volume
Insider net
+$114.7K
12 mo · excl. 2 subscriber-only trades
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Mar 5 Phio Pharmaceuticals reported its 2025 financial results, highlighti…
  • Jun 26 ▲ 1 insider buy $9.9K at $0.9900
  • Aug 18 to Aug 19 ▲ 2 days of insider buys: $27.7K by 2 insiders, avg $1.11
  • Aug 31 ▲ Short interest falls 30.7% to 221.5K
  • Sep 15 to Sep 29 ▲ 5 days of insider buys: $31.4K by 3 insiders, avg $1.03
  • Sep 15 ▲ Short interest falls 32.3% to 149.9K
  • Sep 30 ▲ Short interest falls 40.3% to 89.5K
  • Oct 15 ▼ Short interest jumps 52.5% to 136.4K
  • Oct 30 ▲ Short interest falls 36.7% to 86.3K
  • Nov 9 to Nov 11 ▲ 3 days of insider buys: $45.8K by 3 insiders, avg $0.8274
  • Nov 12 New insider trade: subscribers see the details Unlock
  • Nov 13 New insider trade: subscribers see the details Unlock

Signal stack

Where each data set points today.

  • InsidersMIXED

    4 insiders bought $114.7K. No open-market sales. Excludes 2 subscriber-only trades.

  • InstitutionsMIXED

    Q3 2026: 4 added (0 new), 3 trimmed or exited.

  • AnalystsBULLISH

    6 of 7 rate it Buy or better.

  • Short sellersCOVERING

    Short interest −36.7% to 86.3K shares. 1.5 days to cover, ≈0.7% of shares.

  • TrendDOWNTREND

    19% below its 50-day average. New closing low $0.7520 on Nov 16.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD FIDUCIARY TRUST COADD76,113$78.4K
JANE STREET GROUP, LLCTRIM61,446$63.3K
HRT FINANCIAL LPADD21,485$22.0K
UBS Group AGTRIM3,070$3.2K
BARCLAYS PLCNEAR_EXIT2$2.00
HRT FINANCIAL LPTRIM13,182$13.0K
CITIGROUP INCDOUBLED11,605$11.9K
UBS Group AGNEAR_EXIT5,387$5.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts
Buy 86% rate it Buy or better
Strong Buy2Buy4Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 26, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$114.7K
bought · 4 insiders
$0
sold · 0 insiders · excl. 2 subscriber-only trades
DateInsiderTypeValue
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
BUY
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
BUY
Nov 11, 2026
Deming David H
Director
Nov 11, 2026
BUY$4.4K
Nov 10, 2026
Deming David H
Director
Nov 10, 2026
BUY$5.7K
Nov 9, 2026
Bitterman Robert J
Chairman, Pres. & CEO
Nov 9, 2026
BUY$20.5K
Nov 9, 2026
Plott Ronald Todd
Director
Nov 9, 2026
BUY$15.2K
Sep 29, 2026
Plott Ronald Todd
Director
Sep 29, 2026
BUY$5.2K
Sep 28, 2026
Bitterman Robert J
Chairman, Pres. & CEO
Sep 28, 2026
AWARD400,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
86,344
shares short
-36.7%
vs prior settlement
1.5
days to cover
≈0.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 Insider
🔒 Fresh data, subscribers only
Nov 12, 2026 Insider
🔒 Fresh data, subscribers only
Nov 11, 2026 Insider
Deming David H bought 5,200 shares
Director @ $0.8380 ($4.4K)
Nov 11, 2026 Earnings calendar
PHIO Q3 2026 Earnings Scheduled · 2026-11-11
Nov 5, 2026 SEC
Phio Pharmaceuticals reported Q3 2026 results with a net loss of $4.2M, wider than the $2.4M loss a year ago, driven…
8-K · Impact 5/10
Oct 13, 2026 SEC
Phio Pharmaceuticals announced the successful completion of its first commercial-scale cGMP batch of PH-762 drug…
8-K · Impact 3/10
Sep 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO · ADD
76,113 shares ($78.4K)
Sep 30, 2026 Inst.
JANE STREET GROUP, LLC · TRIM
61,446 shares ($63.3K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 11, 2026
Earnings date
PHIO Q3 2026 Earnings Scheduled · 2026-11-11
Aug 12, 2026
Earnings date
PHIO Q2 2026 Earnings Scheduled, 2026-08-12
May 13, 2026
Earnings date
PHIO Q1 2026 Earnings Scheduled, 2026-05-13
Feb 12, 2026
Short interest
FTD: PHIO, 776,176 shares ($1.0M) failed to deliver
Settlement: 20260212, Price: $1.29, FTD Value: $1,001,267.04, PHIO PHARMACEUTICALS CORP COM
Feb 11, 2026
Short interest
FTD: PHIO, 2,311,187 shares ($2.6M) failed to deliver
Settlement: 20260211, Price: $1.12, FTD Value: $2,588,529.44, PHIO PHARMACEUTICALS CORP COM

SecBot reports

7 filings · 1 bullish · 1 bearish · 1 mixed · 4 neutral
All PHIO filing & press-release reports (7)